2513 New prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC). (September 2015) - Derosa, L.; Guida, A.; Albiges, L.; Massard, C.; Loriot, Y.; Galli, L.; Fizazi, K.; Escudier, B.